Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 407040
Gene Symbol: MIR34A
MIR34A
0.010 AlteredExpression phenotype BEFREE New potential modulators of CYP4F2 enzyme activity in angina pectoris: hsa-miR-24-3p and hsa-miR-34a-5p. 31694408 2020
Entrez Id: 8529
Gene Symbol: CYP4F2
CYP4F2
0.010 AlteredExpression phenotype BEFREE New potential modulators of CYP4F2 enzyme activity in angina pectoris: hsa-miR-24-3p and hsa-miR-34a-5p. 31694408 2020
Entrez Id: 83706
Gene Symbol: FERMT3
FERMT3
0.010 AlteredExpression phenotype BEFREE Platelets from twelve patients with STEMI and twelve patients with non-ischemic chest pain were isolated and analyzed for kindlin-3 protein levels and intracellular localization by immunoblotting and two-dimensional gel electrophoresis. 31817594 2019
Entrez Id: 283131
Gene Symbol: NEAT1
NEAT1
0.010 AlteredExpression phenotype BEFREE Real-time PCR (RT-PCR) was used to determine the relative RNA expression of NEAT1 and its potential target microRNA, miR-129-5p, in the plasma of patients with acute myocardial infarction, heart failure, and angina, as well as in H2O2-treated H9c2 cells. 31815867 2019
Entrez Id: 55034
Gene Symbol: MOCOS
MOCOS
0.010 Biomarker phenotype BEFREE Multinomial logistic regression analyses compared activation level with clinically meaningful changes (≥3.0 points, generic; ≥10.0 points, disease-specific) in generic physical (SF-36v2 Physical Component Summary [PCS]), generic mental (SF-36v2 Mental Component Summary [MCS]), and disease-specific (Seattle Angina Questionnaire [SAQ]) HRQOL from 1 to 3 and 1 to 6 months after hospitalization, adjusting for potential sociodemographic and clinical confounders. 28574974 2019
Entrez Id: 1906
Gene Symbol: EDN1
EDN1
0.010 Biomarker phenotype BEFREE MATERIAL AND METHODS To evaluate the effects of angina pectoris, the differences of scores of the Seattle angina questionnaire (SAQ), vascular endothelial function [endothelial progenitor cells (EPCs), nitric oxide (NO) and endothelin 1 (ET-1)], and inflammatory factors [tumor necrosis factor a (TNF-α), hypersensitive C-reactive protein (hs-CRP), interleukin-6 (IL-6)] in 2 groups were assessed before and after treatment. 30636768 2019
Entrez Id: 3309
Gene Symbol: HSPA5
HSPA5
0.010 Biomarker phenotype BEFREE Severity of AP was assessed at baseline of the BIP trial using the Canadian Cardiovascular Society angina classification. 31446880 2019
Entrez Id: 8936
Gene Symbol: WASF1
WASF1
0.010 Biomarker phenotype BEFREE Prevalence of angina and co-morbid conditions among older adults in six low- and middle-income countries: Evidence from SAGE Wave 1. 30879938 2019
Entrez Id: 2720
Gene Symbol: GLB1
GLB1
0.010 Biomarker phenotype BEFREE The most important biological activities of Artemisia's alkaloids are including hepatoprotective, local anesthetic, β-galactosidase, and antiparasitic activities; treatment of angina pectoris, opening blocked arteries, as a sleep-inducing agents and inhibition of HIV viral protease, CYP450, melanin biosynthesis, human carbonic anhydrase, [3H]-AEA metabolism, kinases, and DNA polymerase β<sup>1</sup> . 31453659 2019
Entrez Id: 5067
Gene Symbol: CNTN3
CNTN3
0.010 Biomarker phenotype BEFREE Multinomial logistic regression analyses compared activation level with clinically meaningful changes (≥3.0 points, generic; ≥10.0 points, disease-specific) in generic physical (SF-36v2 Physical Component Summary [PCS]), generic mental (SF-36v2 Mental Component Summary [MCS]), and disease-specific (Seattle Angina Questionnaire [SAQ]) HRQOL from 1 to 3 and 1 to 6 months after hospitalization, adjusting for potential sociodemographic and clinical confounders. 28574974 2019
Entrez Id: 4184
Gene Symbol: SMCP
SMCP
0.010 Biomarker phenotype BEFREE Multinomial logistic regression analyses compared activation level with clinically meaningful changes (≥3.0 points, generic; ≥10.0 points, disease-specific) in generic physical (SF-36v2 Physical Component Summary [PCS]), generic mental (SF-36v2 Mental Component Summary [MCS]), and disease-specific (Seattle Angina Questionnaire [SAQ]) HRQOL from 1 to 3 and 1 to 6 months after hospitalization, adjusting for potential sociodemographic and clinical confounders. 28574974 2019
Entrez Id: 4351
Gene Symbol: MPI
MPI
0.010 Biomarker phenotype BEFREE In women with angina and no obstructive CAD, CMD is associated with longer IVCT and higher MPI indicating a link between CMD and subtle alternations of systolic and combined measures of cardiac time intervals. 31012159 2019
Entrez Id: 55906
Gene Symbol: ZC4H2
ZC4H2
0.010 Biomarker phenotype BEFREE Multinomial logistic regression analyses compared activation level with clinically meaningful changes (≥3.0 points, generic; ≥10.0 points, disease-specific) in generic physical (SF-36v2 Physical Component Summary [PCS]), generic mental (SF-36v2 Mental Component Summary [MCS]), and disease-specific (Seattle Angina Questionnaire [SAQ]) HRQOL from 1 to 3 and 1 to 6 months after hospitalization, adjusting for potential sociodemographic and clinical confounders. 28574974 2019
Entrez Id: 7432
Gene Symbol: VIP
VIP
0.010 Biomarker phenotype BEFREE PubMed, Cochrane, Embase, Google Scholar, Chongqing VIP Chinese Science and Technology Periodical Database, China National Knowledge Infrastructure, and Wanfang database were searched up to January 2019 for randomized controlled trials that assessed the impact of corn silk decoction on total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol in patients with angina pectoris. 31423665 2019
Entrez Id: 2662
Gene Symbol: GDF10
GDF10
0.010 Biomarker phenotype BEFREE Severity of AP was assessed at baseline of the BIP trial using the Canadian Cardiovascular Society angina classification. 31446880 2019
Entrez Id: 55907
Gene Symbol: CMAS
CMAS
0.010 Biomarker phenotype BEFREE The majority of patients (85.7%) had CSS class III or IV angina and 10% had non-ST elevation myocardial infarction. 31543030 2019
Entrez Id: 5362
Gene Symbol: PLXNA2
PLXNA2
0.010 Biomarker phenotype BEFREE In this large SRCT cohort, angiography had limited diagnostic value whereas OCT could be used to define disease characteristics and guide treatment of lesions inducing angina pectoris and/or silent myocardial ischemia. 29199266 2018
Entrez Id: 80316
Gene Symbol: PPP1R2C
PPP1R2C
0.010 Biomarker phenotype BEFREE NYHA functional class I-IV, absence of angina (OR 0.818, 95% CI 0.729-0.918), and BMI≥40 (OR 0.592, 95% CI 0.494-0.709) resulted in an odds ratio of ≤1. 27612569 2018
Entrez Id: 8743
Gene Symbol: TNFSF10
TNFSF10
0.010 AlteredExpression phenotype BEFREE At baseline, lower TRAIL level was associated with more coronary artery calcium (OR = 1.2 per SD, 95%CI 1.1-1.5, p = 0.02), and with history of myocardial infarction (OR = 2.3 per SD, 95%CI 1.2-4.5, p = 0.02), angina (OR = 1.6 per SD, 95%CI 1.1-2.6, p = 0.03), and angioplasty (OR = 1.8 per SD, 95%CI 1.0-3.1, p = 0.04) in models adjusted for cardiovascular risk-factors, FEV<sub>1</sub>, and emphysema. 30509711 2018
Entrez Id: 3482
Gene Symbol: IGF2R
IGF2R
0.010 Biomarker phenotype BEFREE Fifty patients with angina (65 ± 9 years of age) and 20 age-matched healthy control subjects underwent adenosine stress CMR (1.5- and 3-T) to assess left ventricular function, inducible ischemia (myocardial perfusion reserve index [MPRI]; myocardial blood flow [MBF]), and infarction (late gadolinium enhancement). 29495996 2018
Entrez Id: 23158
Gene Symbol: TBC1D9
TBC1D9
0.010 GeneticVariation phenotype BEFREE Studies indicate that there is an increased serum concentration of amlodipine (a calcium channel blocker used to treat hypertension and angina) in patients having mutant multidrug resistance 1 (MDR1) gene. 28656587 2018
Entrez Id: 947
Gene Symbol: CD34
CD34
0.010 Biomarker phenotype BEFREE The relative frequency of angina was 0.78 (95% CI 0.63-0.98; P = 0.032), 0.66 (0.48-0.91; P = 0.012), and 0.58 (0.38-0.88; P = 0.011) at 3-, 6- and 12-months in auto-CD34+ compared with placebo patients. 29315376 2018
Entrez Id: 354
Gene Symbol: KLK3
KLK3
0.010 GeneticVariation phenotype BEFREE ( n = 73); 2) Angina: treatment options ( n = 88); 3) Breast cancer: surgical options ( n = 265); 4) Prostate Specific Antigen (PSA) test: yes or no? 29078054 2018
Entrez Id: 8842
Gene Symbol: PROM1
PROM1
0.010 Biomarker phenotype BEFREE Intra-myocardial delivery of autologous CD133+ stem cells is safe and feasible but does not show a significant improvement in the QoL or angina pectoris symptoms in patients with chronic myocardial ischemia. 30211929 2018
Entrez Id: 26291
Gene Symbol: FGF21
FGF21
0.010 Biomarker phenotype BEFREE The present study indicates that FGF21 has a strong correlation and precise predictability for increased risks of UAP, that is independent of traditional risk factors of angina pectoris. 30185439 2018